$92.44+1.12 (+1.23%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
LivaNova (LIVN) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~7.6%/yr (FY21→FY25), net margin −17.5%. Worth your attention in FY25: Share count (+7.7%) and Capex step-up ($81.0M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲10.7%
1,388.1
FY21→FY25CAGR +7.6%/yr
Net income ($M)—
−242.5
one-off year: see footnoteCAGR —
Free cash flow ($M)▲27.5%
173.3
capex stepped upCAGR +22.5%/yr
Diluted EPS—
−4.45
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+7.7%
50.6mn → 54.5mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex step-up
$81.0M
▲72% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-17¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 68.2% → 67.7%. Net margin -17.5% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 1,506,914.0 | 1,388,053.0 | 1,253,437.0 | 1,153,545.0 | 1,021,805.0 | 1,035,365.0 | ▲10.7% | +7.6% |
Cost of revenue | 484,671.0 | 448,183.0 | 399,953.0 | 397,725.0 | 314,577.0 | 329,371.0 | ▲12.1% | +8.0% |
Gross profit | 1,022,243.0 | 939,870.0 | 853,484.0 | 755,820.0 | 707,228.0 | 705,994.0 | ▲10.1% | +7.4% |
Research & development | 212,165.0 | 185,764.0 | 182,514.0 | 193,817.0 | 155,805.0 | 183,414.0 | ▲1.8% | +0.3% |
Selling, general & admin | 599,989.0 | 548,813.0 | 508,876.0 | 502,699.0 | 469,243.0 | 471,904.0 | ▲7.8% | +3.8% |
Total operating expenses | 860,285.0 | 740,480.0 | 724,433.0 | 824,318.0 | 783,980.0 | 706,778.0 | ▲2.2% | +1.2% |
Operating incomefeeds ROC rank | 161,958.0 | 199,390.0 | 129,051.0 | −68,498.0 | −76,752.0 | −784.0 | ▲54.5% | — |
Other income, net | −41,586.0 | −420,171.0 | −40,741.0 | −12,728.0 | 1,610.0 | −123,688.0 | — | — |
Pretax income | 120,372.0 | −220,781.0 | 88,310.0 | −81,226.0 | −75,142.0 | −124,472.0 | — | — |
Income tax | −76,750.0 | 21,639.0 | 25,058.0 | −98,876.0 | 11,051.0 | 11,198.0 | ▼13.6% | +17.9% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | 196,063.0 | −242,471.0 | 63,234.0 | 17,546.0 | −86,246.0 | −135,818.0 | — | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 3.01 | −4.45 | 1.16 | 0.32 | −1.61 | −2.68 | — | — |
Diluted shares (mn) | 57.37 | 54.55 | 54.57 | 54.21 | 53.47 | 50.63 | ▼0.0% | +1.9% |
| Margins | ||||||||
Gross margin51st pct in Healthcare | 67.8% | 67.7% | 68.1% | 65.5% | 69.2% | 68.2% | ▼0.4pp | −0.5pp |
Operating margin | 10.7% | 14.4% | 10.3% | −5.9% | −7.5% | −0.1% | ▲4.1pp | +14.4pp |
Net margin73rd pct in Healthcare | 13.0% | −17.5% | 5.0% | 1.5% | −8.4% | −13.1% | ▼22.5pp | −4.4pp |
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 122% vs a −9% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was 28% vs a −9% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 6 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-25 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was LivaNova's revenue last fiscal year?
LivaNova reported revenue of $1,388.1M in fiscal 2025, up 10.7% from fiscal 2024.
What was LivaNova's net income?
LivaNova reported net income of −$242.5M in fiscal 2025, a net margin of −17.5%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

